STAT3 and Obesity: We found that HJJPD reduces hyperleptinemia, alleviates chronic inflammatory response, improves leptin resistance of obese mice, and plays a role in treating simple obesity by activating the LEP-mediated JAK2-STAT3 signaling pathway in liver and adipose tissue.